Yossi Bornstein

Yossi Bornstein has a long and successful career in the fields of entrepreneurship, biomed, clinical research, regulatory affairs, R&D support, and marketing and business development services. In 2000, they founded and became the CEO of Shizim Group, a leading Israeli-based holding group. In 2011, they co-founded and served as Director of Microbot Medical Israel and The Biomed Management Education Center. In 2013, they co-founded and served as Director of XACT Robotics. In 2018, they became Managing Partner of MRC - Medical Research Center. In 2010, they founded and served as Chairman of Dolphin Medical. In 2002, they founded and served as Chairman of GCP Clinical Studies. In 2021, they co-founded and became Chairman of IdentifAI Genetics and External Director of Can Fite BioPharma (CANFY). In 2015, they founded and served as Director of Cann10 - Medical Cannabis.

Yossi Bornstein obtained a Bsc. in Agriculture from The Hebrew University of Jerusalem between 1980 and 1984. Yossi then went on to earn a Master of Arts Program in Interdisciplinary Studies, Holistic Health and the Arts from Lesley University / Israel Extension, Graduate School of Arts & Social Sciences, Netanya between 2001 and 2002, with a field of study in Holistic Health.